The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety and feasibility of yttrium-90 (Y-90) treatment for primary and metastatic liver tumors at a community hospital.
Brandon Keith Martinez
No relevant relationships to disclose
Niraj K. Gupta
No relevant relationships to disclose
Vincent Flanders
No relevant relationships to disclose
Kannan Natarajan
No relevant relationships to disclose
Marc Underhill
No relevant relationships to disclose
Jeff Cooke
No relevant relationships to disclose